Clinical significance of medication reconciliation in children admitted to a UK pediatric hospital: observational study of neurosurgical patients.
BACKGROUND
In December 2007, the National Institute for Health and Clinical Excellence and the National Patient Safety Agency in the UK (NICE-NPSA) published guidance that recommends all adults admitted to hospital receive medication reconciliation, usually by pharmacy staff. A costing and report tool was provided indicating a resource requirement of 12.9 million pounds for England per year. Pediatric patients are excluded from this guidance.


OBJECTIVE
To determine the clinical significance of medication reconciliation in children on admission to hospital.


METHODS
A prospective observational study included pediatric patients admitted to a neurosurgical ward at Birmingham Children's Hospital, Birmingham, England, between September 2006 and March 2007. Medication reconciliation was conducted by a pharmacist after the admission of each of 100 consecutive eligible patients aged 4 months to 16 years. The clinical significance of prescribing disparities between pre-admission medications and initial admission medication orders was determined by an expert multidisciplinary panel and quantified using an analog scale. The main outcome measure was the clinical significance of unintentional variations between hospital admission medication orders and physician-prescribed pre-admission medication for repeat (continuing) medications.


RESULTS
Initial admission medication orders for children differed from prescribed pre-admission medication in 39% of cases. Half of all resulting prescribing variations in this setting had the potential to cause moderate or severe discomfort or clinical deterioration. These results mirror findings for adults.


CONCLUSIONS
The introduction of medication reconciliation in children on admission to hospital has the potential to reduce discomfort or clinical deterioration by reducing unintentional changes to repeat prescribed medication. Consequently, there is no justification for the omission of children from the NICE-NPSA guidance concerning medication reconciliation in hospitals, and costing tools should include pediatric patients.
Terry
David R P
DR
Department of Pharmacy, Birmingham Children's Hospital, Birmingham, England. david.terry@bch.nhs.uk
Solanki
Guirish A
GA
Sinclair
Anthony G
AG
Marriott
John F
JF
Wilson
Keith A
KA
D000293:Adolescent; D017028:Caregivers; D002648:Child; D002675:Child, Preschool; D011307:Drug Prescriptions; D005260:Female; D058005:General Practitioners; D006776:Hospitals, Pediatric; D006801:Humans; D007223:Infant; D008297:Male; D059065:Medication Reconciliation / Q000706:statistics & numerical data*; D009493:Neurosurgery / Q000379:methods*; D019370:Observation; D010343:Patient Admission; D010604:Pharmacy; D006113:United Kingdom
Arch Dis Child. 2010 Apr;95(4):250-5
19948664
Arch Intern Med. 2005 Feb 28;165(4):424-9
15738372
Child Care Health Dev. 2004 Nov;30(6):567-70
15527467
Drug Saf. 2006;29(11):1031-47
17061909
Am J Health Syst Pharm. 2004 Aug 15;61(16):1689-95
15540481
Ann Pharmacother. 2006 Mar;40(3):408-13
16492794
Qual Saf Health Care. 2006 Apr;15(2):122-6
16585113
Arch Dis Child. 2007 May;92(5):440-5
17449527
Pediatrics. 2003 Apr;111(4 Pt 1):722-9
12671103
J Hum Nutr Diet. 2006 Oct;19(5):375-81
16961684
Qual Saf Health Care. 2007 Apr;16(2):116-26
17403758
Lancet. 2002 Apr 20;359(9315):1373-8
11978334
Jt Comm J Qual Patient Saf. 2006 Apr;32(4):225-9
16649654
Qual Saf Health Care. 2010 Oct;19(5):371-5
20595717
Qual Saf Health Care. 2007 Feb;16(1):34-9
17301202